Thomas Shen - Apex Biotechnology CEO Chairman
| 1733 Stock | TWD 29.15 0.65 2.28% |
Insider
Thomas Shen is CEO Chairman of Apex Biotechnology Corp
| Phone | 886 3 564 1952 |
| Web | https://www.apexbio.com |
Apex Biotechnology Management Efficiency
The company has return on total asset (ROA) of 0.0434 % which means that it generated a profit of $0.0434 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1279 %, meaning that it generated $0.1279 on every $100 dollars invested by stockholders. Apex Biotechnology's management efficiency ratios could be used to measure how well Apex Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 7 records | INSIDER Age | ||
| Li Xie | Sinphar Pharmaceutical Co | N/A | |
| Reynold Hsu | Standard Chemical Pharmaceutica | N/A | |
| MingDar Fang | China Steel Chemical | 62 | |
| Kuan Fang | China Steel Chemical | N/A | |
| TzuTing Fan | Standard Chemical Pharmaceutica | N/A | |
| Li Li | China Steel Chemical | N/A | |
| ChinTsai Fan | Standard Chemical Pharmaceutica | N/A | |
Management Performance
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0434 |
Apex Biotechnology Corp Leadership Team
Elected by the shareholders, the Apex Biotechnology's board of directors comprises two types of representatives: Apex Biotechnology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Apex. The board's role is to monitor Apex Biotechnology's management team and ensure that shareholders' interests are well served. Apex Biotechnology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Apex Biotechnology's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ben Shen, VP Sales | ||
| Ying Zhu, F Head | ||
| Meng Yang, VP GM | ||
| Thomas Shen, CEO Chairman | ||
| James Chu, Chief Officer | ||
| Chun Wu, VP Spokesman |
Apex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Apex Biotechnology a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0434 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 2.45 B | |||
| Shares Outstanding | 99.95 M | |||
| Shares Owned By Insiders | 15.50 % | |||
| Shares Owned By Institutions | 2.52 % | |||
| Price To Earning | 31.02 X | |||
| Price To Book | 1.46 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Apex Stock Analysis
When running Apex Biotechnology's price analysis, check to measure Apex Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apex Biotechnology is operating at the current time. Most of Apex Biotechnology's value examination focuses on studying past and present price action to predict the probability of Apex Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apex Biotechnology's price. Additionally, you may evaluate how the addition of Apex Biotechnology to your portfolios can decrease your overall portfolio volatility.